Skip to content

Clinical trials

Lung Diseases, Obstructive trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20112
20121
20131
20143
20163
20171
20182
20191
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Royal Brompton & Harefield NHS Foundation Trust4
Imperial College London2
Altesa Biosciences, Inc.1
Northumbria Healthcare NHS Foundation Trust1
Novartis Pharmaceuticals1
Ryme Medical, Inc.1
University of East Anglia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive18
Lung Diseases13
Pulmonary Disease, Chronic Obstructive11
Respiratory Tract Diseases11
Asthma8
Bronchial Diseases7
Bronchitis, Chronic5
Hypersensitivity3
Immune System Diseases3
Pulmonary Emphysema3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.